1025 related articles for article (PubMed ID: 30501821)
1. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.
Archer R; Hock E; Hamilton J; Stevens J; Essat M; Poku E; Clowes M; Pandor A; Stevenson M
Health Technol Assess; 2018 Nov; 22(66):1-294. PubMed ID: 30501821
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
[TBL] [Abstract][Full Text] [Related]
3. What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.
Simpson E; Hock E; Stevenson M; Wong R; Dracup N; Wailoo A; Conaghan P; Estrach C; Edwards C; Wakefield R
Health Technol Assess; 2018 Apr; 22(20):1-258. PubMed ID: 29712616
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
[TBL] [Abstract][Full Text] [Related]
5. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
[TBL] [Abstract][Full Text] [Related]
6. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
[TBL] [Abstract][Full Text] [Related]
7. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.
Graudal N
Scand J Rheumatol Suppl; 2004; 118():1-38. PubMed ID: 15180092
[TBL] [Abstract][Full Text] [Related]
8. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis.
Naredo E; Möller I; Cruz A; Carmona L; Garrido J
Arthritis Rheum; 2008 Aug; 58(8):2248-56. PubMed ID: 18668537
[TBL] [Abstract][Full Text] [Related]
9. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
Vastesaeger N; Xu S; Aletaha D; St Clair EW; Smolen JS
Rheumatology (Oxford); 2009 Sep; 48(9):1114-21. PubMed ID: 19589891
[TBL] [Abstract][Full Text] [Related]
10. Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).
Izumi K; Kaneko Y; Hashizume M; Yoshimoto K; Takeuchi T
PLoS One; 2015; 10(12):e0145468. PubMed ID: 26698858
[TBL] [Abstract][Full Text] [Related]
11. Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.
Dirven L; Visser K; Klarenbeek NB; Ewals JA; Han KH; Peeters AJ; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
Scand J Rheumatol; 2012 Feb; 41(1):15-9. PubMed ID: 22103436
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept.
Neubauer AS; Minartz C; Herrmann KH; Baerwald CGO
Clin Exp Rheumatol; 2018; 36(3):448-454. PubMed ID: 29303709
[TBL] [Abstract][Full Text] [Related]
13. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression.
Aletaha D; Alasti F; Smolen JS
Ann Rheum Dis; 2011 Nov; 70(11):1975-80. PubMed ID: 21803751
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis.
Reeve K; On BI; Havla J; Burns J; Gosteli-Peter MA; Alabsawi A; Alayash Z; Götschi A; Seibold H; Mansmann U; Held U
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD013606. PubMed ID: 37681561
[TBL] [Abstract][Full Text] [Related]
18. Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
Morris NT; Brook J; Ben-Artzi A; Martin W; Kermani TA; Avedikian-Tatosyan L; Karpouzas G; Nagam H; Navarro G; Choi S; Taylor MB; Elashoff D; Kaeley GS; Ranganath VK
Clin Rheumatol; 2021 Dec; 40(12):5055-5065. PubMed ID: 34269927
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study.
Courvoisier N; Dougados M; Cantagrel A; Goupille P; Meyer O; Sibilia J; Daures JP; Combe B
Arthritis Res Ther; 2008; 10(5):R106. PubMed ID: 18771585
[TBL] [Abstract][Full Text] [Related]
20. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Jonsson MK; Sundlisæter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA
Ann Rheum Dis; 2017 Dec; 76(12):2031-2037. PubMed ID: 28814431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
